Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 5
2005 5
2006 5
2007 6
2008 6
2009 15
2010 13
2011 9
2012 6
2013 8
2014 10
2015 7
2016 7
2017 8
2018 8
2019 9
2020 10
2021 7
2022 10
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Mechanical thrombectomy in basilar artery occlusions: impact of first-line strategy as a function of the occlusion level.
Tournier L, Cortese J, Consoli A, Spelle L, Marnat G, Sarov M, Zhu F, Soize S, Burel J, Forestier G, Escalard S, Pop R, Bonnet B, Alias Q, Ognard J, Naggara O, Kyheng M, Lapergue B, Caroff J; ETIS Registry Investigators. Tournier L, et al. J Neurointerv Surg. 2024 Mar 27:jnis-2024-021491. doi: 10.1136/jnis-2024-021491. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38538055
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry.
Prandoni P, Haas S, Fluharty ME, Schellong S, Gibbs H, Tse E, Carrier M, Jacobson B, Ten Cate H, Panchenko E, Verhamme P, Pieper K, Kayani G, Kakkar LA; GARFIELD-VTE investigators. Prandoni P, et al. J Thromb Thrombolysis. 2024 Feb;57(2):312-321. doi: 10.1007/s11239-023-02895-7. Epub 2023 Nov 6. J Thromb Thrombolysis. 2024. PMID: 37932591 Free PMC article.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Among authors: fernandez mg. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
159 results